Estimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysis.
Scenario and cost-effectiveness analyses were used to estimate the effectiveness and efficiency of HIV prevention activities in the USA (1978-2000). Under four conservative scenarios on the course of HIV epidemic that might have occurred had there been no prevention efforts. we estimate that prevention activities averted 204,000-1,585,000 infections at a cost of between 49,700 US dollars and 6400 US dollars per infection prevented (less than the medical costs of treating a case of HIV disease).
Holtgrave
David R
DR
Emory University, Rollins School of Public Health, Center for AIDS Research, Atlanta, GA 30322, USA.
D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D004196:Disease Outbreaks / Q000191:economics / Q000517:prevention & control*; D015658:HIV Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D017048:Health Care Costs; D006293:Health Promotion / Q000191:economics*; D006801:Humans; D015994:Incidence; D011314:Preventive Health Services / Q000191:economics*; D015397:Program Evaluation; D014481:United States / Q000453:epidemiology